The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

As per The Business Research Company’s Antidepressants Global Market Report 2023, The global antidepressants market is expected to grow from $16.44 billion in 2022 to $17.41 billion in 2023 at a compound annual growth rate (CAGR) of 5.9%. The market size of the global antidepressants is expected to grow from $25.52 billion in 2027 at a CAGR of 10.0%.

What was the major driver in the antidepressants market?
The antidepressant market has seen a COVID-19-related surge due to rising anxiety from increased cases and deaths. Existing mental health conditions are exacerbated, leading to higher demand for antidepressants.

View More On The Antidepressants Market Report 2023 – https://www.thebusinessresearchcompany.com/report/antidepressant-global-market-report

What was the key trend in the antidepressants market?
Resistant depression treatment is a significant trend in the antidepressant market. Ketamine, used as anesthesia during surgery, fosters glutamate development and encourages brain connections. This adaptability boosts positive thoughts and behaviors. The FDA approved esketamine, a ketamine derivative, as a nasal spray adjunct to existing antidepressants. It’s prescribed for patients who have tried two antidepressants unsuccessfully.

Which was the largest region in the antidepressants market?
North America was the largest region in the antidepressants market in 2022. Middle East is expected to be the largest growing region in the global antidepressants market during the forecast period. The regions covered in the global antidepressants market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Who are the antidepressants market prominent players?
Major players in the antidepressants market are Allergan PLC., AstraZeneca, Eli Lilly and Company, GlaxoSmithKline PLC., H. Lundbeck AS, Johnson & Johnson, Pfizer Inc., Merck & Co. Inc., Sanofi, Sun Pharmaceuticals Pvt Ltd., Alkermes, Bristol Myers Squibb Company, Teva Pharmaceutical Industries, Eli Lilly and Co., Takeda Pharmaceutical Co. Ltd., Forest laboratories and Akeda Pharmaceutical.

Key antidepressants market segments
The global antidepressants market is segmented –
1) By Product: Selective Serotonin Reuptake Inhibitor (SSRI), Serotonin-norepinephrine Reuptake Inhibitor (SNRI), Tricyclic Antidepressant (TCA), Monoamine Oxidase Inhibitor (MAOI)
2) By Drug Class: Monoamine Oxidase Inhibitors, Serotonin Antagonist And Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, Selective Serotonin Reuptake Inhibitors, Tricyclic Antidepressants
3) By Depressive Disorder: Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder

Request A Sample Of The Global Antidepressants Market Report 2023:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2881&type=smp

The Antidepressants Global Market Report 2023  provides a comprehensive overview on the antidepressants market size, trends and drivers, opportunities, strategies, and companies analysis. Through our reports businesses can effectively analyze data and frame well-informed strategies

View More Related Reports –
Antidiarrhoeals Global Market Report 2023
AntiAsthmatics And COPD Drugs Global Market Report 2023
Analgesics Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model